DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Faculty of Arts and Sciences
  3. FAS Theses and Dissertations
  4. Define the RelationSHIP: INPP5D/SHIP1 regulates inflammasome activation in human microglia

Define the RelationSHIP: INPP5D/SHIP1 regulates inflammasome activation in human microglia

Open/View files
Disseration_Vicky Chou_2.pdf (35.34 MB)
Date
September 9, 2022
Author(s)
Chou, Vicky
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Chou, Vicky. 2022. Define the RelationSHIP: INPP5D/SHIP1 regulates inflammasome activation in human microglia. Doctoral dissertation, Harvard University Graduate School of Arts and Sciences.
Abstract
Microglia and neuroinflammation are implicated in the development and progression of Alzheimer’s disease (AD). However, there are limitations to studying human microglia and utilizing mouse models to study microglia function. Various iPSC-derived microglia-like cell (iMGLs) differentiation protocols have been published within the last few years. Here, one protocol was adapted with modifications to optimize for consistency and yield across genetic backgrounds. With the iMGLs, mix culture models were generated containing iPSC-derived neurons, astrocytes, and microglia. These mixed culture models were then characterized using single cell and single nucleus sequencing to understand then transcriptional changes between a monoculture and mixed culture. To better understand microglia-mediated processes in AD, the function of INPP5D/SHIP1, a gene linked to AD through GWAS was investigated in human brain tissue and iMGL cell cultures. Immunostaining and single nucleus RNA sequencing confirmed that INPP5D expression in the adult human brain is largely restricted to microglia. Examination of prefrontal cortex across a large cohort revealed reduced full length INPP5D protein levels in AD patient brains compared to cognitively normal controls. The functional consequences of reduced INPP5D activity were evaluated in human iMGLs using both pharmacological inhibition of the phosphatase activity of INPP5D and using CRISPR-Cas9 to reduce the number of functional INPP5D copy numbers in half. Unbiased transcriptional and proteomic profiling of these iMGLs suggested an upregulation of innate immune signaling pathways, lower levels of scavenger receptors, and altered inflammasome signaling with INPP5D reduction. INPP5D inhibition induced the secretion of IL-1ß and IL-18, further implicating inflammasome activation. Inflammasome activation was confirmed through visualization of inflammasome formation through ASC immunostaining in INPP5D-inhibited iMGLs, increased cleaved caspase-1, and through rescue of elevated IL-1ß and IL-18 with caspase-1 and NLRP3 inhibitors. In the INPP5D het iMGLs, an increased secretion of both IL-1ß and IL-18 were observed, which was rescued with NLRP3 inhibitor treatment. This work implicates INPP5D as a regulator of inflammasome signaling in human microglia and provides further insight as to how INPP5D function could be linked to the development of AD.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37373675
Subjects

alzheimers

inflammasome

Inpp5d

microglia

ship1

Neurosciences

Collection
FAS Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.